3D Tissue Models 2019 | Boston, MA | Sept. 5 - 6
Presentation - Discovery Track
"Accelerating Drug Development with Human Relevant Stem Cell Based Assays: The Role of Bioengineering the Extracellular Matrix"
Thursday, September 5, 2019 - 2:30 PM - 2:45 PM EST
Dr. Nicholas Geisse, Chief Science Officer, NanoSurface Biomedical
Enhancing the Predictive Success of Complex In Vitro Models for Drug Discovery and Development
The 3D Tissue Models Summit is back in 2019 with world-leading experts to address the key challenges in the preclinical industry. Hear from the latest case studies to deepen your understanding of validation methods and technical advancements that are driving drug development and disease modeling.
Join 120+ industry stakeholders across the regulatory, pharmaceutical, biotech and academic landscape for effective cross-talk and interactive discussions. Discover how to apply the latest insight to enhance the predictive power of your therapeutic pipeline.
Session Track: Drug Discovery and Target Validation
Industry cross-talk between FDA, NIH and IQ consortia on how the latest partnerships are driving preclinical 3D guidelines towards scientific advancement.
Greater focus the latest validation techniques to enhance reproducibility and increase the therapeutic success of drug candidates.
Revealing insight into the latest imaging techniques incorporated into translational studies to improve disease modeling in cardiac, CNS, fibrosis models and many more.
Learn more at https://3d-tissuemodels.com/.
We will be at World Pharma Week 2019 in Boston, MA from June 17-20, 2019!
Join us for the bridging luncheon talk for iPS cells for Disease Modeling and Drug Discovery - Pluripotent Stem Cells on Wednesday, June 19 - 12:00-13:00. Lunch will be provided.
You can also find us at Booth 346.
Four world class congresses for pharmaceutical decision makers, including Biomarker World Congress World Preclinical Congress, IO Pharma Congress, and Digital Health Pharma Congress - One Powerful Event.
Learn more about WPW 2019 here.
Founded in 1961, the Society of Toxicology (SOT) is a professional and scholarly organization of scientists from academic institutions, government, and industry representing the great variety of scientists who practice toxicology in the US and abroad. The Society’s mission is to create a safer and healthier world by advancing the science and increasing the impact of toxicology.
The NanoSurface team will be in Baltimore, MD, March 3-5 for Biophysical Society 2019!
Dr. Ghazizadeh, our Applications Scientist, will be giving a technical talk on "Biomimetic Cell Culture Platforms for Enhancing Cell Biology Studies" on Monday, March 4th, 3:30 PM at Room 303.
Meet us at Booth 505 and learn how mimicking structural (nanotopography), mechanical, and electrochemical cues of the Extracellular Matrix can help you produce more physiologically relevant data.
As science becomes increasingly interdisciplinary, the Biophysical Society Annual Meeting continues its long-held reputation for bringing together leading scientists from the all over the world who work at the interface of the life, physical, and computational sciences.
The dynamic five-day Meeting provides attendees with opportunities to share their latest unpublished findings and learn the newest emerging techniques and applications.
Despite its nearly 6,500 attendees, the Meeting is noted for maintaining its “small meeting” feel beginning with the Saturday subgroup symposia, which allow attendees to meet within their scientific communities. It is also known for its vitality, demonstrated by the over 900 highly interactive daily poster presentations, the more than 500 speakers selected from submitted abstracts, the many career development programs for those working in academia, industry, and agencies throughout the world, and its advocacy and education programs.
SLAS2019 will provide a unique combination of education, access to innovative technologies and intelligent peer networking, delivering unmatched value for professionals and students looking to discover the latest life sciences technologies and how they can be applied to drive research objectives.